Dacula, Al-alshrie D.
HRN: 28-47-33 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2026
CEFUROXIME 750MG (VIAL)
01/27/2026
02/03/2026
IV
750mg
Q8H
POTT'S DISEASE
Checking Initial Appropriateness
01/28/2026
CEFTRIAXONE 1G (VIAL)
01/28/2026
02/04/2026
IV
1g
Q12
UTI
Checking Initial Appropriateness
02/03/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/03/2026
02/10/2026
IV
1.5g
Q6h
Pott’s Disease
Checking Initial Appropriateness